Drug Profile
MK 499
Alternative Names: L 706000; MK 0499Latest Information Update: 03 Aug 2006
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Class III antiarrhythmics
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias